Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 1

Atypical Form of Retinopathy of Prematurity

Atipik Prematüre Retinopatisi

Pages
69–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So, anti-VEGF’s are in the fore ground in their treatment either alone or combined with argon laser photocoagulation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atypical forms of Retinopathy of Prematurity; including an aggressive posterior retinopathy of prematurity (APROP), that can be seen despite normal birth week and weight, exhibits atypical localization (Zone 3), rapidly progression, independent progression without stage and cannot be controlled by treatment.
📊
Key Findings & Data:APROP is a disease that requires careful examination and making critical decision, which can progress rapidly if not treated and result in retinal detachment and blindness.
💡
Conclusion & Impact:So, anti-VEGF’s are in the fore ground in their treatment either alone or combined with argon laser photocoagulation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Atypical forms of Retinopathy of Prematurity; including an aggressive posterior retinopathy of prematurity (APROP), that can be seen despite normal birth week and weight, exhibits atypical localization (Zone 3), rapidly progression, independent progression without stage and cannot be controlled by treatment. APROP is a disease that requires careful examination and making critical decision, which can progress rapidly if not treated and result in retinal detachment and blindness. APROP requires attention and experience in terms of recognition and treatment approach. So, anti-VEGF’s are in the fore ground in their treatment either alone or combined with argon laser photocoagulation

Özet

Atipik prematüre retinopatileri; normal doğum haftası ve kiloya rağmen görülebilen, atipik yerleşim gösterebilen (Zon 3), hızlı progresyon gösteren, evreden bağımsız ilerleyebilen ve tedaviyle kontrol altına alınamayabilen, agresif posterior ROP'u (APROP) da içeren önemli bir gruptur. APROP dikkatli muayene ve kritik karar vermeyi gerektiren, tedavi edilmediği takdirde hızlı ilerleyip retina dekolmanı ve körlükle sonuçlanabilen bir hastalıktır. APROP tanınması ve tedavi yaklaşımı açısından dikkat ve tecrübe gerektirir. Tedavisinde ise anti- VEGF'lerin tek başlarına ya da argon lazer fotokoagülasyonla kombine uygulamaları ile ön plana çıkmaktadır

🔖

Cite This Article

TÖK, L., SEYREK, L., TÖK, Ö. (2018). Atypical Form of Retinopathy of Prematurity. Güncel Retina Dergisi, Cilt: 2 - Sayı: 1, 69–72. https://ajindex.com/articles/192621

References (4)

  1. Gilbert C, Foster A. Childhood blindness in the context of Vision 2020: the right to sight. Bull World Health Organ 2001;79(3):227 32
  2. Cebeci Z, Kır N. Prematüre Retinopatisinde Evreleme ve Klinik Seyir. Retina-Vitreus 2012:Özel Sayı:95-101. 3.Gilbert C, Fielder A, Gordillo L, et all, on behalf of the İnternational NOROP Group. Characteristic of babies with severe retinopathy of prematurity in countries with low, modarete and high levels of development: implications for screening programmes. Pediatr Electron Pages. 2005;115(5):518-525
  3. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123(7):991-9
  4. Azad R, Trese MT. Retinopathy of prematurity. Ed:Levent Tök. 2013;5:57 -58. 6.Benson WE. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1995;473-521 7.Pollard ZF. Persistent hyperplastic primary vitreous: diagnosis, treatment and results. Trans Am Ophthalmol Soc. 1997;95:487-549. 8.Sims K. NDP-related retinopathies. GeneRewiews. http://www.geneclinics.org/profiles/norrie. Updated August 8,2006. Accessed January 28, 2007. 9.Scheuerle AE. Male cases of incontinentia pigmenti: case report and review. Am J Med Genet. 1998;77(3):201-218. 10.Drenser KA, Trese MT, Capone A Jr. Aggressive posterior retinopathy of prematurity. Retina 2010;30(4 Suppl):S37-40. 11.Vinekar A, Trese MT, Capone A Jr; Photographic Screening for Retinopathy of Prematurity (PHOTO-ROP) Cooperative Group. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol 2008;145(3):548-55. 12.Yokoi T, Hiraoka M, Miyamoto M, et al. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 2009;116(7):1377-82. 13.Khwarg SI, Yu HG, Yu YS. The outcome of cryotherapy for retinopathy of prematurity (ROP) according to ROP location. Korean J Ophthalmol 1996;10(2):92-6. 14.Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina. 2006;26 (7 suppl):S11–S15. 15.Yokoi T, Hiraoka M, Miyamoto M, et al. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology. 2009;116(7):1377–1382. 16.Fortes Filho JB, Eckert GU, Procianoy L, Barros CK, Procianoy RS. Incidence and risk factors for retinopathy of prematurity in very l